| Heritage Health Care & Rehab Inc | |
| 1101 Snows Mill Avenue, Tuscaloosa, Alabama 35406 | |
| (205) 759-5179 | |
| Name | Heritage Health Care & Rehab Inc |
|---|---|
| Location | 1101 Snows Mill Avenue, Tuscaloosa, Alabama |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 216 |
| Occupancy Rate | 55.09% |
| Medicare ID (CCN) | 015371 |
| Legal Business Name | Heritage Health Care & Rehab, Inc. |
| Ownership Type | For Profit - Individual |
| NPI Number | 1184719247 |
| Organization Name | HERITAGE HEALTH CARE & REHAB, INC. |
| Address | 1101 Snows Mill Avenue, Tuscaloosa, AL 35406 |
| Phone Number | 205-759-5179 |
News Archive
GenVec, Inc. has announced that the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has executed its sixth option period (year seven) under its multi-year collaboration with GenVec to develop and manufacture novel adenovector-based HIV vaccines.
A recent study aimed to use their own classification of different SARS-CoV-2 lineages that would help monitor their genetic features and geographical origins.
Water is likely to become an even more important factor in determining human well-being in the near future as the world's population continues to increase. While it is clear that the demand for water will steadily rise, it also appears that water supply could decline as a result of major shifts in the world's climate.
International tennis superstar Andy Murray has teamed up with one of Scotland's leading innovation centres to highlight the potential of technology to provide more efficient and effective health and care services in the UK and across the world.
Eckert & Ziegler Strahlen- und Medizintechnik AG, a firm specializing in radioactive compounds for the treatment of cancer, has renewed the approval of its drug YTTRIGA (Yttrium-90 chloride) by the European Commission. Five years ago the European Medicines Agency EMA approved this drug for the first time and as a result of the current renewal process the drug has now been granted an indefinite approval.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
GenVec, Inc. has announced that the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has executed its sixth option period (year seven) under its multi-year collaboration with GenVec to develop and manufacture novel adenovector-based HIV vaccines.
A recent study aimed to use their own classification of different SARS-CoV-2 lineages that would help monitor their genetic features and geographical origins.
Water is likely to become an even more important factor in determining human well-being in the near future as the world's population continues to increase. While it is clear that the demand for water will steadily rise, it also appears that water supply could decline as a result of major shifts in the world's climate.
International tennis superstar Andy Murray has teamed up with one of Scotland's leading innovation centres to highlight the potential of technology to provide more efficient and effective health and care services in the UK and across the world.
Eckert & Ziegler Strahlen- und Medizintechnik AG, a firm specializing in radioactive compounds for the treatment of cancer, has renewed the approval of its drug YTTRIGA (Yttrium-90 chloride) by the European Commission. Five years ago the European Medicines Agency EMA approved this drug for the first time and as a result of the current renewal process the drug has now been granted an indefinite approval.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $6500 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 11.32 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.81 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 33.33 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.04 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.16 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.5 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.86 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 20 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 90.19 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 5.3 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 18.44 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 25.96 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.18 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.82 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 71.59 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 81.34 | 82.93 |
News Archive
GenVec, Inc. has announced that the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has executed its sixth option period (year seven) under its multi-year collaboration with GenVec to develop and manufacture novel adenovector-based HIV vaccines.
A recent study aimed to use their own classification of different SARS-CoV-2 lineages that would help monitor their genetic features and geographical origins.
Water is likely to become an even more important factor in determining human well-being in the near future as the world's population continues to increase. While it is clear that the demand for water will steadily rise, it also appears that water supply could decline as a result of major shifts in the world's climate.
International tennis superstar Andy Murray has teamed up with one of Scotland's leading innovation centres to highlight the potential of technology to provide more efficient and effective health and care services in the UK and across the world.
Eckert & Ziegler Strahlen- und Medizintechnik AG, a firm specializing in radioactive compounds for the treatment of cancer, has renewed the approval of its drug YTTRIGA (Yttrium-90 chloride) by the European Commission. Five years ago the European Medicines Agency EMA approved this drug for the first time and as a result of the current renewal process the drug has now been granted an indefinite approval.
› Verified 4 days ago
Heritage Health Care & Rehab Inc Location: 1101 Snows Mill Avenue, Tuscaloosa, Alabama 35406 Phone: (205) 759-5179 |